Genomic risk scores in prostate cancer: polygenic yes, but are they poly-ancestral?

被引：0
|
作者：
Basu, Arnab [1 ,2 ]
Rais-Bahrami, Soroush [1 ,3 ,4 ]
机构：
[1] Univ Alabama Birmingham, Heersink Sch Med, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Heersink Sch Med, ONeal Comprehens Canc Ctr, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Heersink Sch Med, Dept Urol, Fac Off Tower 1120,510 20th St S, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Heersink Sch Med, Dept Radiol, Birmingham, AL 35294 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2024年 / 116卷 / 05期
关键词：
MEN;
D O I：
10.1093/jnci/djae025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：635 / 636
页数：2
相关论文
共 37 条
  • [31] An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study
    Cheng, Yifei
    Wu, Lang
    Xin, Junyi
    Ben, Shuai
    Chen, Silu
    Li, Huiqin
    Zhao, Lingyan
    Wang, Meilin
    Cheng, Gong
    Du, Mulong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [32] Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing
    Lenz, Lauren
    Clegg, Wyatt
    Iliev, Diana
    Kasten, Chelsea R.
    Korman, Howard
    Morgan, Todd M.
    Hafron, Jason
    DeHaan, Alexander
    Olsson, Carl
    Tutrone Jr, Ronald F.
    Richardson, Timothy
    Cline, Kevin
    Yonover, Paul M.
    Jasper, Jeff
    Cohen, Todd
    Finch, Robert
    Slavin Jr, Thomas P.
    Gutin, Alexander
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, : 427 - 434
  • [33] When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level
    Falagario, Ugo Giovanni
    Chakravarty, Dimple
    Martini, Alberto
    Shahait, Mohammed
    El-Fahmawi, Ayah
    Jambor, Ivan
    Lantz, Anna
    Grannas, David
    Ratnani, Parita
    Parekh, Sneha
    Lundon, Dara
    Haines, Kenneth
    Cormio, Luigi
    Carrieri, Giuseppe
    Kyprianou, Natasha
    Kattan, Michael W.
    Klein, Eric A.
    Wiklund, Peter
    Lee, David I.
    Tewari, Ash
    WORLD JOURNAL OF UROLOGY, 2022, 41 (1) : 85 - 92
  • [34] Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial
    Murphy, Adam B.
    Abern, Michael R.
    Liu, Li
    Wang, Heidy
    Hollowell, Courtney M. P.
    Sharifi, Roohollah
    Vidal, Patricia
    Kajdacsy-Balla, Andre
    Sekosan, Marin
    Ferrer, Karen
    Wu, Shoujin
    Gallegos, Marlene
    King-Lee, Patrice
    Sharp, Lisa K.
    Ferrans, Carol E.
    Gann, Peter H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15) : 1660 - +
  • [35] Prognostic value of selected preoperative inflammation-based scores in patients with high-risk localized prostate cancer who underwent radical prostatectomy
    Shu, Kunpeng
    Zheng, Yu
    Chen, Junru
    Li, Wenbin
    Jiang, Ke
    ONCOTARGETS AND THERAPY, 2018, 11 : 4551 - 4558
  • [36] External validation of genomic classifier-based risk-stratification tool to identify candidates for adjuvant radiation therapy in patients with prostate cancer
    Lee, David I.
    Shahait, Mohammed
    Dalela, Deepansh
    Keeley, Jacob
    Lal, Priti
    Vapiwala, Neha
    Abdollah, Firas
    WORLD JOURNAL OF UROLOGY, 2021, 39 (09) : 3217 - 3222
  • [37] Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply
    Berlin, A.
    Dal Pra, A.
    Bristow, R. G.
    BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1045)
1234